Cleared Traditional

K844072 - DERMIZIP SKIN CLOSURE DEVICE (FDA 510(k) Clearance)

K844072 · Kells Medical, Inc. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1984
Decision
18d
Days
-
Risk

K844072 is an FDA 510(k) clearance for the DERMIZIP SKIN CLOSURE DEVICE.

Submitted by Kells Medical, Inc. (Burr Ridge, US). The FDA issued a Cleared decision on November 5, 1984 after a review of 18 days - a notably fast clearance cycle.

This device falls under the General & Plastic Surgery FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Kells Medical, Inc. devices

Submission Details

510(k) Number K844072 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 18, 1984
Decision Date November 05, 1984
Days to Decision 18 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
96d faster than avg
Panel avg: 114d · This submission: 18d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code -
Device Class -